Subject
Neurology (clinical),Neurology
Reference6 articles.
1. Long-term outcomes following CAR T cell therapy: what we know so far;Cappell;Nat Rev Clin Oncol.,2023
2. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies;Sorkhabi;Front Immunol.,2023
3. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus;Mackensen;Nat Med.,2022
4. Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy;Bouziana;Crit Rev Oncol Hematol.,2021
5. Ciltacabtagene autoleucel, an anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy, for relapsed/refractory multiple myeloma: CARTITUDE-1 2-year follow-up;Martin;J Clin Oncol.,2023